{"id":"NCT01561898","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"A Long-Term Study of JNS007ER in Patients With Schizophrenia","officialTitle":"A Long-Term Study of JNS007ER in Patients With Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2012-03-23","resultsPosted":"2012-09-10","lastUpdate":"2012-09-28"},"enrollment":228,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"Paliperidone extended-release (JNS007ER)","otherNames":[]}],"arms":[{"label":"Paliperidone extended-release (JNS007ER)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the safety of JNS007ER 3-12 mg once daily in patients with schizophrenia over a long term period.","primaryOutcome":{"measure":"Incidence of Adverse Events","timeFrame":"48 weeks","effectByArm":[{"arm":"Entire Group","deltaMin":97.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":228},"commonTop":["Blood prolactin increased","Nasopharyngitis","Schizophrenia","Weight increased","Extrapyramidal disorder"]}}